![Colleen Tupper](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Colleen Tupper
Vorstandsvorsitzender bei
BIODELIVERY SCIENCES INTERNATIONAL, INC.
Vermögen: 2 Mio $ am 31.05.2026
Profil
Colleen Tupper is currently President, CEO, CFO & Secretary at BioDelivery Sciences International, Inc., Chief Financial Officer & Executive Vice President at Collegium Pharmaceutical, Inc. since 2021, and Chief Financial Officer at Arius Pharmaceuticals, Inc. Former roles include President, Treasurer & Director at Dyax Corp., Vice President-Commercial Finance at Shire US, Inc., Co-President at Baxalta, Inc., and Senior Vice President & CFO-US Business Unit at Takeda Pharmaceuticals U.S.A., Inc. from 2019 to 2021.
Education includes undergraduate studies at Franklin Pierce University.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 31.03.2026 | 61’553 ( 0.19% ) | 2 Mio $ | 31.05.2026 |
Aktive Positionen von Colleen Tupper
| Unternehmen | Position | Beginn |
|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC. | Finanzdirektor/CFO | 24.05.2021 |
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Vorstandsvorsitzender | - |
Arius Pharmaceuticals, Inc.
 Arius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for surgical and oncology patients | Finanzdirektor/CFO | - |
Ehemalige bekannte Positionen von Colleen Tupper
| Unternehmen | Position | Ende |
|---|---|---|
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Corporate Officer/Principal | 01.04.2021 |
Shire US, Inc.
 Shire US, Inc. Medical DistributorsDistribution Services Sells and markets prescription medicines within the United States | Corporate Officer/Principal | - |
| BAXALTA INC | Präsident | - |
| DYAX CORP. | Präsident | - |
Ausbildung von Colleen Tupper
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
15
Beziehungen ersten Grades
8
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 8 |
|---|---|
Dyax Corp.
 Dyax Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of novel biotherapeutics | Health Technology |
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial stage pharmaceutical company to patients living with chronic pain | Health Technology |
Collegium Pharmaceutical, Inc.
 Collegium Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Baxalta, Inc.
 Baxalta, Inc. Pharmaceuticals: MajorHealth Technology Engages in research, development and manufacture of therapies and biopharmaceutical products | Health Technology |
Shire US, Inc.
Shire US, Inc. Medical DistributorsDistribution Services Sells and markets prescription medicines within the United States | Distribution Services |
Arius Pharmaceuticals, Inc.
Arius Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals for surgical and oncology patients | Health Technology |
Takeda Pharmaceuticals U.S.A., Inc.
Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Franklin Pierce University
 Franklin Pierce University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
